Jenburkt Pharmaceuticals Ltd. Financials

12:18 Jun 19

Jenburkt Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1305.00
-31.65 (-2.37%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. Financials

Jenburkt Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1305.00
-31.65 (-2.37%)
12:18 Jun 19
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

13

Weakness

4

Opportunity

0

Threats

0

18.66 %

ROE %

16.34 %

ROA %

0.00

EPS

389.22

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
109.29 123.98 136.75 141.97 151.69
Operating Expenses +
89.45 96.73 106.38 108.85 111.3
Raw Material
26.91 33.72 31.67 30.8 29.77
Increase Decrease in Cost
3.18 -2.28 1.34 -0.39 -0.12
Other Manufacturing Expense
0.34 0.63 0.8 0.73 0
Employee Cost
32.38 36.49 38.81 42.49 45.54
Miscellaneous Expenses
66.9 72.13 74.86 80.04 78.63
Operating Profit
19.84 27.25 30.37 33.12 40.39
Other Income
4.31 4.95 5.12 4.67 6.72
Depreciation
2.04 1.9 2.26 2.34 2.73
Interest
0.47 0.43 0.37 0.27 0.45
Profit before tax and exceptio..
21.64 29.87 32.86 35.18 43.93
Exceptional Items
0 0 0 0 0
PBT
21.64 29.87 32.86 35.18 43.93
Provision for Taxation
5.14 7.57 8.26 9.2 11.87
Net Profit
16.5 22.3 24.61 25.98 32.06
NET Profit after MI
0 0 0 0 0
EPS
35.96 48.58 53.9 58.86 72.65
Operating Profit Margin (%)
18.15 21.98 22.21 23.33 26.63
Net Profit Margin (%)
15.1 17.99 18 18.3 21.14

Jenburkt Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 46.70 46.70 46.70 46.70 47.20
FII 0.00 0.00 0.00 0.00 0.00
MF 0.00 0.00 0.00 0.00 0.00
Others 0.10 0.10 0.00 0.00 0.00
Shareholder Shares Holding %
Download Our App On: